EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Soluble Nanomedicine Against Soluble Neurosensitizers to Effectively Relieve Osteoarthritis Pain and Joint Damage

Junyan Liu, Feixiang Ding, Jiayi Li, Min Liu, Lingyu Su, Zixi Wang, Congying Pi, Shilong Jiang, Zhaokui Zeng, Changjun Li, Chao Zeng, Guanghua Lei und 1 weitere

Exploration · 2026-10 · 6 (5)

DOI: 10.1002/exp2.70233 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Exploration, online erschienen am 08.10.2026. Verfasst von Junyan Liu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics The Third Xiangya Hospital Central South University Changsha China. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Central South University, Key Research and Development Program of Hunan Province of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeting soluble neurosensitizers in the osteoarthritis (OA) joint cavity is a key strategy for alleviating OA pain. Soluble neurosensitizers are ubiquitous in the joint cavity and cause uncontrollable growth and sensitization of nociceptor axons therein. However, eliminating these soluble nerve growth factors (NGFs) remains a considerable challenge due to the diversity of neurosensitizers and the complexity of OA pathology. This study introduces an innovative soluble nanodrug (LAC)‐based strategy to eliminate three key neurosensitizers (H + , NGF, and netrin‐1) to simultaneously relieve OA‐associated pain and joint damage. In two animal model experiments, LAC significantly reduced pain and alleviated OA progression by reducing synovial inflammation and inhibiting cartilage and subchondral bone damage. This strategy of using soluble nanomedicine to counter soluble neurosensitizers not only provides inspiration for eliminating pain, but also sheds light on possible solutions for advancing OA treatment strategies.

Schlagwörter

Stichwörter der Autor:innen

joint painneurosensitizerosteoarthritissensory perceptionsynovial inflammation

Autor:innen und Institutionen

  • Department of Orthopaedics The Third Xiangya Hospital Central South University Changsha China.
  • Department of Orthopaedics Xiangya Hospital Central South University Changsha China.
  • Xiangya School of Pharmaceutical Sciences Central South University Changsha China.
  • Department of Pharmacology and Chemical Biology College of Basic Medical Sciences Shanghai Jiao Tong University School of Medicine Shanghai China.
  • Department of Pharmacy Xiangya Hospital Central South University Changsha China.
  • Key Laboratory of Aging-Related Bone and Joint Diseases Prevention and Treatment Ministry of Education Xiangya Hospital Central South University Changsha China.

Förderung

  • National Natural Science Foundation of China
  • Central South University
  • Key Research and Development Program of Hunan Province of China

Zitieren

APA

Liu, J., Ding, F., Li, J., Liu, M., Su, L., Wang, Z., Pi, C., Jiang, S., Zeng, Z., Li, C., Zeng, C., Lei, G., & Ai, K. (2026). Soluble Nanomedicine Against Soluble Neurosensitizers to Effectively Relieve Osteoarthritis Pain and Joint Damage. Exploration, 6(5). https://doi.org/10.1002/exp2.70233

Vancouver

Liu J, Ding F, Li J, Liu M, Su L, Wang Z, et al. Soluble Nanomedicine Against Soluble Neurosensitizers to Effectively Relieve Osteoarthritis Pain and Joint Damage. Exploration. 2026;6(5). doi:10.1002/exp2.70233

BibTeX
@article{Liu2026,
  author = {Liu, Junyan and Ding, Feixiang and Li, Jiayi and Liu, Min and Su, Lingyu and Wang, Zixi and Pi, Congying and Jiang, Shilong and Zeng, Zhaokui and Li, Changjun and Zeng, Chao and Lei, Guanghua and Ai, Kelong},
  title = {Soluble Nanomedicine Against Soluble Neurosensitizers to Effectively Relieve Osteoarthritis Pain and Joint Damage},
  journal = {Exploration},
  year = {2026},
  volume = {6},
  number = {5},
  doi = {10.1002/exp2.70233}
}
Kostenlos starten →